Marked gender differences in progression of mild cognitive impairment over 8 years
Abstract
This study examined whether, among subjects with mild cognitive impairment (MCI), women progressed at faster rates than men.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 21, 2015
- Source ID
- 10.1016/j.trci.2015.07.001
Entities
People
- Bharath G. Rathakrishnan
- David M. Marks
- Jeffrey R. Petrella
- Katherine A. Lin
- Kingshuk Roy Choudhury
- P. Murali Doraiswamy
- The Alzheimer’s Disease Neuroimaging Initiative*
Organizations
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Biogen
- Canadian Institutes of Health Research
- Duke University
- Eisai
- Eli Lilly and Company
- GE HealthCare
- Innogenetics
- Laboratoires Servier
- Medpace
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Novartis
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense